Health screening and follow up test
Biomarkers are measurable indicators found in blood and other body samples that reflect how the body is functioning. They help researchers understand biological changes over time. In our cardiovascular disease (CVD) trial, biomarker testing provides valuable insights into cardiovascular and metabolic health.
Biomarkers
In the cardiovascular disease (CVD) trial, participants undergo comprehensive biomarker testing at the start (baseline) and during follow-up visits. These include measures of blood values, hormones, inflammation, kidney function, and liver function. Tracking these biomarkers over time helps reveal how stem cell treatment may influence cardiovascular and metabolic health.
For patients participating in our other trials, biomarker analysis can be added as an additional service. This allows individuals to gain further insights into their biological response and overall health, although it is not part of the trial protocol itself.
Infectious Diseases
HbsAg (Hepatitis B)
HIV I & II
Syphilis VDRL
Anti HCV (Hepatitis C)
Metabolic
Albumin
ALP
ALT
AST
Potassium
Sodium
Lipid Profile
Total Cholesterol
LDL-Cholesterol
HDL-Cholesterol
Triglycerides
APO A
APO B
Blood Values and Complete Blood Count
HbA1c
Homocysteine
Glucose
Ferritin
CBC
Hormones
Testosterone (male)
TSH (female)
Inflammation
High-sensitive CRP
ESR
Kidney
Creatinine
Liver
Total Bilirubin
Lipid Profile
Total Cholesterol
LDL-Cholesterol
HDL-Cholesterol
Triglycerides
APO A
APO B
Blood Values and Complete Blood Count
HbA1c
Homocysteine
Glucose
Ferritin
CBC
Hormones
Testosterone (male)
TSH (female)
Inflammation
High-sensitive CRP
ESR
Kidney
Creatinine
Liver
Total Bilirubin
Cytokines and Chemokines
Eotaxin
IL-1 RA
IL-1b
IL-2
IL-4
IL-6
IL-7
IL-10
IL-12 p70
IL-13
IL-15
IL-17A
MIP-1A
MIP-1b
IFN-g
MCP-1
GM-CSF
IP-10
TGF-a
TNF-a
TNF-b
VEGF A
Aging
Telomere Length
Total Telomere length (kb)
Average length per telomere end (kb)
DNA Methylation
Total Methylation (5-mC%/total DNA)
5-mC%/cytosine content
Histone 3 Modification
Histone H3K4 methylation (%)
Immunoprofiling
Innate Immune Cells
Total (CD3-CD56+) NK cells %
Mature (CD16+CD56+) NK cells %
Immature (CD16-CD56-) NK cells %
Total monocytes (CD3-CD19-CD14+) %
Classical (CD14hiCD16-) monocytes %
Intermediate (CD14+CD16+) monocytes %
Non-classical (CD16hiCD14+) monocytes %
Adaptive Immune Cells
CD4+ (CD3+CD19-) helper T cells %
Naive (CD45RA+CD27+) CD4+ helper T cells %
Central memory (CD45RA-CD27+) CD4+ helper T cells %
Effector (CD45RA-CD27-) CD4+ helper T cells %
EMRA (CD45RA+CD27-) CD4+ helper T cells %
CXCR3+ CD4+ helper T cells %
Regulatory T cells (CD25+ FOXP3+) %
Activated regulatory T cells (CD25hiFOPX3hi)
CD8+ (CD3+CD19-) cytotoxic T cells %
Naive (CD45RA+CD27+) CD8+ cytotoxic T cells %
Central memory (CD45RA-CD27+) CD8+ T cells %
Effector memory (CD45RA-CD27-) CD8+ cytotoxic T cells %
EMRA (CD45RA+CD27-) CD8+ cytotoxic T cells %
CD19+ B cells %
Naive (IgD+CD27-) B cells %
Immature transitional (CD5+CD38+) B cells %
IgD+ memory (IgD+CD27+) B cells %
Class-switched Memory (IgD-CD27+) B cells %
Total memory (CD27+) B cells %
Plasmablast (CD27+CD38+) %
BAFFR+ B cells %
Regulatory B cells %